Neue Suche | Kongressdetail
Druckansicht
 
 

Gene Therapy for Rare Disorders Europe

evvnt Platform / evvnt
Kongressthemen
Gene Therapy for Rare Disorders Europe is devoted to overcoming these challenges, focusing specifically on the clinical, manufacturing, regulatory and reimbursement hurdles that need to be overcome for gene therapies to reach their full potential.

Uniting leaders from Pfizer, GSK, Shire and uniQure, this meeting focusses specifically on delivering practical insights into developing the next generation of gene therapies that promise improved efficacy, enhanced safety and commercial viability.
Kongressorganizer (PCO)
Hanson Wade
 

Anfragen und Anmeldung:

https://go.evvnt.com/155837-0
Herr Customer Services
44 203 141 8700
 
Kategorien
Gesundheitsversorgung
Sprache
Englisch
Kongressgebühr
GBP 2.498,00
(Conference Earlybird (Book by 22/09/17): GBP 1799 Conference + 1 Workshop Earlybird (Book by 22/09/17): GBP 2298 Workshop only: GBP 599 Conference (Standard rate): GBP 1999 Conference + 1 Workshop (Standard rate): GBP 2498)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

FFG - 7. EU-RahmenprogrammCharité International AcademyÄrztekammer für WienEuropean Public Health Association (EUPHA)Ärzte der WeltOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTreeÖsterreichische Akademie der Ärzte

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage